North Carolina · G0010

Administration Of Hepatitis B Vaccine in North Carolina

North Carolina Medicare Avg
$27.80
6% below national avg
National Medicare Avg
$29.70
All states combined
Billed Charge (NC)
$48.24
What providers submit
Est. Commercial (NC)
$60.61
National avg: $66.53
Est. Cash / Self-Pay (NC)
$34.12
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

2.1K
Services in NC
680
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in North Carolina

Provider Medicare Services
Connel, Stefani MD $28.95 131
Mcmurray, Roger M.D. $29.17 38
Dave, Darshan MD $29.17 34
Macdonald, Gigi MD $29.17 32
Adams, James MD $29.17 30
Jennings, Stuart M.D. $29.17 27
Craig, Christopher DO $29.17 21
Burkett, Jessica MD $24.50 17
Provo, Jessica MD $29.17 15
Chiu, Vernon M.D. $29.17 13

North Carolina Pricing in Context

In North Carolina, CPT code G0010 (Administration Of Hepatitis B Vaccine) carries an average Medicare payment of $27.80 — 6% below the national benchmark of $29.70. 680 providers across the state submitted claims for this procedure in 2023, performing 2.1K total services. Individual payments in NC ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in North Carolina is $48.24, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because North Carolina sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Temporary Procedures procedures, the estimated commercial insurance price in North Carolina lands near $60.61, with self-pay cash prices typically around $34.12. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Administration Of Hepatitis B Vaccine cost in North Carolina?

The average Medicare payment for Administration Of Hepatitis B Vaccine in North Carolina is $27.80, which is 6% below the national average of $29.70. Providers in NC typically bill $48.24 for this procedure.

What does Administration Of Hepatitis B Vaccine cost with insurance in North Carolina?

With commercial insurance in North Carolina, Administration Of Hepatitis B Vaccine costs an estimated $60.61. Without insurance, the estimated cash price is $34.12. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Administration Of Hepatitis B Vaccine in North Carolina?

680 providers in North Carolina billed Medicare for Administration Of Hepatitis B Vaccine in 2023, performing 2.1K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Administration Of Hepatitis B Vaccine cheaper in North Carolina than the national average?

Yes — Administration Of Hepatitis B Vaccine costs 6% below the national average in North Carolina. The state average Medicare payment is $27.80 compared to $29.70 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial